Developer docs
API playgroundTry for free, no card

Search company profiles

Zydex

Full company profile

uuid003dixn

Namestring
Zydex
Legal namestring
Zydex Limited
Websiteurl
zydex.co.uk
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Zydex Limited is a privately held UK pharmaceutical broker that facilitates the import and export of pharmaceutical products for healthcare-sector organisations and related industries in the UK and internationally. The company sits between global pharmaceutical manufacturers/suppliers and buyers, generating revenue through transaction-based fees on pharmaceutical trades. It is incorporated as a private limited company in the United Kingdom and operates without a disclosed parent entity, institutional investors, funding history, or capital structure information.

The company's marketed portfolio comprises ten branded pharmaceutical products sourced from third-party manufacturers and spanning multiple therapeutic categories: Pseudovac (polyvalent vaccine for Pseudomonas aeruginosa infections), Fluvaxin (influenza prevention for workplace wellness), Rovatinex (urolithiasis treatment), Akineton/Biperiden (Parkinson's disease treatment), FATOL Riemser anti-tuberculosis drugs, Provag (peroral probiotic for vaginal dysbacteriosis), SiderAl (iron-deficient anemia treatment, ranked first in iron-bearing drug sales in Italy), Gestalis (prenatal multivitamins with vitamin K, selenium, liposome iron, and algal DHA), Dapson Fatol (autoimmune disease treatment), and DiCappa (osteoporosis prevention combining vitamins K2 and D3, listed as forthcoming). The underlying technology is described as a pharmaceutical brokering and international trade facilitation platform, with no proprietary technical components, patents, trademarks, or certifications disclosed.

Zydex's go-to-market is sales-led and relationship-driven, with self-reported 20-plus years of sector experience and an extensive network of global manufacturers and suppliers spanning Europe to Asia. Distribution is direct enterprise supply to healthcare organisations; marketing channels are limited to a website contact form and direct phone/email contact. Pricing is quote-based and not publicly disclosed. The company maintains two UK locations — headquarters at 42-44 Bishopsgate in the City of London financial district and an operational office in Slough — and operates with 11–50 employees. No named customers, certifications, regulatory actions, partnerships, or named management team are disclosed in the available data.

Short descriptiontext

Zydex Limited is a UK-based pharmaceutical broker that facilitates import and export of branded medicines, vaccines, and medical products for healthcare-sector organisations across European and Asian markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical brokering, pharmaceutical import export, pharmaceutical wholesale, medical supplies sourcing, pharmaceutical distribution services
Industry3 codes
PRIMARYHLAIAJAK
Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Wholesale Trade Agents and Brokers42512
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution and Brokering
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Brokering Services
TypeTransaction Fee
Description

The company facilitates import and export of pharmaceutical supplies, brokering deals between buyers and suppliers in the healthcare sector. Revenue is generated through transaction-based fees on pharmaceutical product trades.

zydex.co.uk
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Zydex Limited brokers the import and export of pharmaceutical products, sourcing branded medicines, vaccines, and medical products from a global network of manufacturers and suppliers and supplying them to healthcare sector organisations and related industries in the UK and international markets (Europe to Asia). The company operates a relationship-driven brokerage model with quote-based pricing, credit lines, and discount structures available to patrons.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Zydex Limited is a pharmaceutical broker specializing in the import and export of pharmaceutical products for the UK and international markets. The company offers a portfolio of branded pharmaceutical products sourced from global manufacturers, including: Pseudovac (polyvalent vaccine), Fluvaxin (influenza prevention), Rovatinex (urolithiasis treatment), Akineton (Parkinson's disease treatment), FATOL Riemser (anti-tuberculosis drugs), Provag (probiotic for vaginal dysbacteriosis), SiderAl (iron-deficient anemia treatment), Gestalis (prenatal vitamins), Dapson Fatol (autoimmune disease treatment), and DiCappa (osteoporosis prevention). The company operates from Slough and serves markets across Europe and Asia.

Product and service10 records
1Pseudovac vaccine
CategoryPharmaceutical product (vaccine)
Description

A unique polyvalent vaccine used for prevention and treatment of Pseudomonas aeruginosa blue pus infection. Prescribed as both a preventive and therapeutic drug to create active resistance against infection and reduce risk of bacteremia and sepsis.

2Fluvaxin
CategoryPharmaceutical product (influenza prevention)
Description

Highly effective influenza prevention solution designed for workplace wellness, providing total safety at minimum cost to help employees stay healthy throughout the year.

3Rovatinex
CategoryPharmaceutical product (urolithiasis therapy)
Description

Urolithiasis treatment that removes gravel and fine concrements through spasmolytic, diuretic, antimicrobial and anti-inflammatory effects of natural terpenes.

4Akineton
CategoryPharmaceutical product (Parkinson's disease treatment)
Description

Parkinson's disease treatment (INN Biperiden) included in standard drug lists and Federal Medical Manual for administration of drugs.

5FATOL Riemser anti-tuberculosis drug portfolio
CategoryPharmaceutical product (anti-tuberculosis drugs)
Description

Anti-tuberculosis drug portfolio from FATOL Riemser Co., including treatments for resistant strains. Products are GMP compliant with high-quality materials and equipment.

6Provag
CategoryPharmaceutical product (probiotic)
Description

Peroral probiotic used to treat and prevent vaginal dysbacteriosis, addressing health problems, discomfort and related conditions caused by dysfunctional vaginal micro flora.

7SiderAl
CategoryPharmaceutical product (iron-deficiency anemia treatment)
Description

Innovative iron-deficient anemia treatment, ranked number one in iron-bearing drug sales in Italy. Has no strong side effects and can be administered during pregnancy and breast feeding.

8Gestalis
CategoryPharmaceutical product (prenatal vitamins)
Description

Unique multivitamin set for pregnant and nursing mothers containing vitamin K, selenium, liposome iron, and herbal docosahexaenoic acid extracted from algae.

9Dapson Fatol
CategoryPharmaceutical product (autoimmune disease treatment)
Description

Autoimmune disease treatment (INN Dapson) used for conditions including inflammatory articular rheumatism, multiple sclerosis, type I diabetes, regional enteritis, ulcerative colitis, and pemphigus.

10DiCappa
CategoryPharmaceutical product (osteoporosis therapy)
Description

Osteoporosis prevention and correction treatment containing vitamins K2 and D3. Ensures optimized mineralization of osseous tissue without risk of arterial vessel calcification, suitable for patients with various osteoporosis manifestations.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

UK-headquartered specialty pharmaceutical distributor and access provider supplying unlicensed, niche, and hard-to-source medicines globally. Directly comparable in specialty pharma access/distribution model and geographic reach to Zydex.

TypeBroad incumbent
Description

One of the largest pharmaceutical wholesalers and distributors in the UK and Europe (part of Walgreens Boots Alliance). Operates across the full pharma distribution value chain and represents the scaled incumbent against which niche players like Zydex compete.

3Drug Houses of Australia (DHA)
TypeRegional player
Description

Australian pharmaceutical wholesaler and distributor serving hospital and retail channels. Comparable in wholesale distribution model and product breadth but operates in Asia-Pacific rather than UK/Europe like Zydex.

TypeBroad incumbent
Description

European pharmaceutical wholesale and retail group operating across multiple countries. Comparable as a broad-line incumbent in the same pharma distribution space, with overlapping customer types (pharmacies, hospitals) to Zydex.

5AAH Pharmaceuticals
TypeBroad incumbent
Description

Major UK pharmaceutical wholesaler serving community pharmacies, hospitals, and dispensing doctors. Represents a full-line incumbent competitor with overlapping downstream customer base to Zydex's enterprise healthcare buyers.

6Trident Pharmaceuticals
TypeDirect peer
Description

UK-based specialty pharmaceutical distributor focused on parallel imports and unlicensed medicines. Comparable niche competitor in the same secondary-market pharmaceutical distribution category as Zydex.

TypeBroad incumbent
Description

International specialty pharmaceutical company active in distribution, licensing, and supply of niche medicines across Europe and emerging markets. Comparable as a specialty pharma intermediary with cross-border reach similar to Zydex.

TypeDirect peer
Description

UK-based pharmaceutical wholesaler and distributor with a similar specialty and parallel-import focus, serving healthcare organisations across multiple therapeutic areas. Closely comparable in business model, customer base, and product mix to Zydex.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zydex

Pharmaceutical Distribution and Brokeringzydex.co.uk

Zydex Limited is a UK-based pharmaceutical broker that facilitates import and export of branded medicines, vaccines, and medical products for healthcare-sector organisations across European and Asian markets.

What Zydex does

Zydex Limited is a privately held UK pharmaceutical broker that facilitates the import and export of pharmaceutical products for healthcare-sector organisations and related industries in the UK and internationally. The company sits between global pharmaceutical manufacturers/suppliers and buyers, generating revenue through transaction-based fees on pharmaceutical trades. It is incorporated as a private limited company in the United Kingdom and operates without a disclosed parent entity, institutional investors, funding history, or capital structure information.

The company's marketed portfolio comprises ten branded pharmaceutical products sourced from third-party manufacturers and spanning multiple therapeutic categories: Pseudovac (polyvalent vaccine for Pseudomonas aeruginosa infections), Fluvaxin (influenza prevention for workplace wellness), Rovatinex (urolithiasis treatment), Akineton/Biperiden (Parkinson's disease treatment), FATOL Riemser anti-tuberculosis drugs, Provag (peroral probiotic for vaginal dysbacteriosis), SiderAl (iron-deficient anemia treatment, ranked first in iron-bearing drug sales in Italy), Gestalis (prenatal multivitamins with vitamin K, selenium, liposome iron, and algal DHA), Dapson Fatol (autoimmune disease treatment), and DiCappa (osteoporosis prevention combining vitamins K2 and D3, listed as forthcoming). The underlying technology is described as a pharmaceutical brokering and international trade facilitation platform, with no proprietary technical components, patents, trademarks, or certifications disclosed.

Zydex's go-to-market is sales-led and relationship-driven, with self-reported 20-plus years of sector experience and an extensive network of global manufacturers and suppliers spanning Europe to Asia. Distribution is direct enterprise supply to healthcare organisations; marketing channels are limited to a website contact form and direct phone/email contact. Pricing is quote-based and not publicly disclosed. The company maintains two UK locations — headquarters at 42-44 Bishopsgate in the City of London financial district and an operational office in Slough — and operates with 11–50 employees. No named customers, certifications, regulatory actions, partnerships, or named management team are disclosed in the available data.

Zydex firmographics

Firmographics
Name
Zydex
Legal name
Zydex Limited
Website
https://zydex.co.uk
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Zydex Limited is a UK-based pharmaceutical broker that facilitates import and export of branded medicines, vaccines, and medical products for healthcare-sector organisations across European and Asian markets.
Ownership category
akta.pro rank

Zydex industry classification

Industry
Product category
Pharmaceutical Distribution and Brokering
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Wholesale Trade Agents and Brokers (42512)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAK
Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Pharmaceutical brokering
  • Pharmaceutical import export
  • Pharmaceutical wholesale
  • Medical supplies sourcing
  • Pharmaceutical distribution services

Where Zydex is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Zydex business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical Brokering Services: The company facilitates import and export of pharmaceutical supplies, brokering deals between buyers and suppliers in the healthcare sector. Revenue is generated through transaction-based fees on pharmaceutical product trades.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Zydex product offering

Product offering

Core offering

Zydex Limited brokers the import and export of pharmaceutical products, sourcing branded medicines, vaccines, and medical products from a global network of manufacturers and suppliers and supplying them to healthcare sector organisations and related industries in the UK and international markets (Europe to Asia). The company operates a relationship-driven brokerage model with quote-based pricing, credit lines, and discount structures available to patrons.

Product overview

Zydex Limited is a pharmaceutical broker specializing in the import and export of pharmaceutical products for the UK and international markets. The company offers a portfolio of branded pharmaceutical products sourced from global manufacturers, including: Pseudovac (polyvalent vaccine), Fluvaxin (influenza prevention), Rovatinex (urolithiasis treatment), Akineton (Parkinson's disease treatment), FATOL Riemser (anti-tuberculosis drugs), Provag (probiotic for vaginal dysbacteriosis), SiderAl (iron-deficient anemia treatment), Gestalis (prenatal vitamins), Dapson Fatol (autoimmune disease treatment), and DiCappa (osteoporosis prevention). The company operates from Slough and serves markets across Europe and Asia.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pseudovac vaccine A unique polyvalent vaccine used for prevention and treatment of Pseudomonas aeruginosa blue pus infection. Prescribed as both a preventive and therapeutic drug to create active resistance against infection and reduce risk of bacteremia and sepsis.
  • Fluvaxin Highly effective influenza prevention solution designed for workplace wellness, providing total safety at minimum cost to help employees stay healthy throughout the year.
  • Rovatinex Urolithiasis treatment that removes gravel and fine concrements through spasmolytic, diuretic, antimicrobial and anti-inflammatory effects of natural terpenes.
  • Akineton Parkinson's disease treatment (INN Biperiden) included in standard drug lists and Federal Medical Manual for administration of drugs.
  • FATOL Riemser anti-tuberculosis drug portfolio Anti-tuberculosis drug portfolio from FATOL Riemser Co., including treatments for resistant strains. Products are GMP compliant with high-quality materials and equipment.
  • Provag Peroral probiotic used to treat and prevent vaginal dysbacteriosis, addressing health problems, discomfort and related conditions caused by dysfunctional vaginal micro flora.
  • SiderAl Innovative iron-deficient anemia treatment, ranked number one in iron-bearing drug sales in Italy. Has no strong side effects and can be administered during pregnancy and breast feeding.
  • Gestalis Unique multivitamin set for pregnant and nursing mothers containing vitamin K, selenium, liposome iron, and herbal docosahexaenoic acid extracted from algae.
  • Dapson Fatol Autoimmune disease treatment (INN Dapson) used for conditions including inflammatory articular rheumatism, multiple sclerosis, type I diabetes, regional enteritis, ulcerative colitis, and pemphigus.
  • DiCappa Osteoporosis prevention and correction treatment containing vitamins K2 and D3. Ensures optimized mineralization of osseous tissue without risk of arterial vessel calcification, suitable for patients with various osteoporosis manifestations.

Companies that use Zydex

Customer profile

Segments2 records

Ideal customer profiles2 records

Zydex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Zydex partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Zydex competitors and assessment

Company assessment

Direct peers

  • Clinigen Group: UK-headquartered specialty pharmaceutical distributor and access provider supplying unlicensed, niche, and hard-to-source medicines globally. Directly comparable in specialty pharma access/distribution model and geographic reach to Zydex.
  • Trident Pharmaceuticals: UK-based specialty pharmaceutical distributor focused on parallel imports and unlicensed medicines. Comparable niche competitor in the same secondary-market pharmaceutical distribution category as Zydex.
  • Mawdsley-Brooks: UK-based pharmaceutical wholesaler and distributor with a similar specialty and parallel-import focus, serving healthcare organisations across multiple therapeutic areas. Closely comparable in business model, customer base, and product mix to Zydex.

Broad incumbents

  • Alliance Healthcare: One of the largest pharmaceutical wholesalers and distributors in the UK and Europe (part of Walgreens Boots Alliance). Operates across the full pharma distribution value chain and represents the scaled incumbent against which niche players like Zydex compete.
  • Phoenix Group: European pharmaceutical wholesale and retail group operating across multiple countries. Comparable as a broad-line incumbent in the same pharma distribution space, with overlapping customer types (pharmacies, hospitals) to Zydex.
  • AAH Pharmaceuticals: Major UK pharmaceutical wholesaler serving community pharmacies, hospitals, and dispensing doctors. Represents a full-line incumbent competitor with overlapping downstream customer base to Zydex's enterprise healthcare buyers.
  • Ethypharm: International specialty pharmaceutical company active in distribution, licensing, and supply of niche medicines across Europe and emerging markets. Comparable as a specialty pharma intermediary with cross-border reach similar to Zydex.

Regional players

  • Drug Houses of Australia (DHA): Australian pharmaceutical wholesaler and distributor serving hospital and retail channels. Comparable in wholesale distribution model and product breadth but operates in Asia-Pacific rather than UK/Europe like Zydex.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Zydex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zydex leadership team

Management profile

Number of profiles

Zydex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zydex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zydex

What does Zydex do?

Zydex Limited brokers the import and export of pharmaceutical products, sourcing branded medicines, vaccines, and medical products from a global network of manufacturers and suppliers and supplying them to healthcare sector organisations and related industries in the UK and international markets (Europe to Asia). The company operates a relationship-driven brokerage model with quote-based pricing, credit lines, and discount structures available to patrons.

Is Zydex a public or private company?

Zydex is a private company. It is classified as unknown and is currently operating.

When was Zydex founded?

Zydex was founded in -1. It employs 11 to 50 people.

Where is Zydex based?

Zydex is headquartered in London, United Kingdom, in the Europe region.

How does Zydex make money?

One revenue line is on record: pharmaceutical Brokering Services.

Who are Zydex's main competitors?

Direct peers on record are Clinigen Group, Trident Pharmaceuticals and Mawdsley-Brooks. Broad incumbents are Alliance Healthcare, Phoenix Group, AAH Pharmaceuticals and Ethypharm. Drug Houses of Australia (DHA) is listed as a regional player.

Does Zydex have an API?

No public API is recorded for Zydex.

What industry is Zydex in?

Zydex's product category is Pharmaceutical Distribution and Brokering. Its primary akta.pro industry code is HLAIAJAK, Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales